These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2417761)

  • 1. New aspects of vaccine development.
    Liew FY
    Clin Exp Immunol; 1985 Nov; 62(2):225-41. PubMed ID: 2417761
    [No Abstract]   [Full Text] [Related]  

  • 2. The potential of synthetic peptides for vaccines.
    Steward MW; Howard CR
    Med Lab Sci; 1985 Oct; 42(4):376-87. PubMed ID: 2417087
    [No Abstract]   [Full Text] [Related]  

  • 3. [Viral vaccines produced by gene technology and synthesis].
    Hess RG
    Tierarztl Prax; 1986; 14(1):9-14. PubMed ID: 2424142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice.
    Shinoda K; Xin KQ; Jounai N; Kojima Y; Tamura Y; Okada E; Kawamoto S; Okuda K; Klinman D; Okuda K
    Vaccine; 2004 Sep; 22(27-28):3676-90. PubMed ID: 15315847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of new technologies on vaccine development.
    Winther MD; Dougan G
    Biotechnol Genet Eng Rev; 1984; 2():1-39. PubMed ID: 6085856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.
    Thomson SA; Sherritt MA; Medveczky J; Elliott SL; Moss DJ; Fernando GJ; Brown LE; Suhrbier A
    J Immunol; 1998 Feb; 160(4):1717-23. PubMed ID: 9469429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clustered epitopes within the Gag-Pol fusion protein DNA vaccine enhance immune responses and protection against challenge with recombinant vaccinia viruses expressing HIV-1 Gag and Pol antigens.
    Bolesta E; Gzyl J; Wierzbicki A; Kmieciak D; Kowalczyk A; Kaneko Y; Srinivasan A; Kozbor D
    Virology; 2005 Feb; 332(2):467-79. PubMed ID: 15680412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.
    McKenna TS; Rieder E; Lubroth J; Burrage T; Baxt B; Mason PW
    J Biotechnol; 1996 Jan; 44(1-3):83-9. PubMed ID: 8717390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses.
    Wagner R; Böltz T; Deml L; Modrow S; Wolf H
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1261-9. PubMed ID: 7687647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.
    Smith CL; Dunbar PR; Mirza F; Palmowski MJ; Shepherd D; Gilbert SC; Coulie P; Schneider J; Hoffman E; Hawkins R; Harris AL; Cerundolo V
    Int J Cancer; 2005 Jan; 113(2):259-66. PubMed ID: 15386406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
    Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA
    Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines for the future?
    Ada GL
    Aust J Exp Biol Med Sci; 1982 Dec; 60(6):549-69. PubMed ID: 6763523
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes.
    Thomson SA; Elliott SL; Sherritt MA; Sproat KW; Coupar BE; Scalzo AA; Forbes CA; Ladhams AM; Mo XY; Tripp RA; Doherty PC; Moss DJ; Suhrbier A
    J Immunol; 1996 Jul; 157(2):822-6. PubMed ID: 8752934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic monitoring of the renal transplant recipient.
    Suthanthiran M; Garovoy MR
    Urol Clin North Am; 1983 May; 10(2):315-25. PubMed ID: 6222530
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant vaccinia viruses expressing immunoglobulin variable regions efficiently and selectively protect mice against tumoral B-cell growth.
    BenAmmar-Ceccoli S; Humblot S; Crouzier R; Acres B; Kieny MP; Herlyn D; Pasquali JL; Martin T
    Cancer Gene Ther; 2001 Oct; 8(10):815-26. PubMed ID: 11687905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1.
    Ishii N; Fukushima J; Kaneko T; Okada E; Tani K; Tanaka SI; Hamajima K; Xin KQ; Kawamoto S; Koff W; Nishioka K; Yasuda T; Okuda K
    AIDS Res Hum Retroviruses; 1997 Nov; 13(16):1421-8. PubMed ID: 9359662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.
    Promkhatkaew D; Matsuo K; Pinyosukhee N; Thongdeejaroen W; Leang-Aramgul P; Sawanpanyalert P; Warachit P
    Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):273-81. PubMed ID: 19323012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful generation of cytotoxic T lymphocytes specific for self immunoglobulin-determinants on B lymphocytes.
    Dohi Y; Higasa M; Nishimura M; Hirayama A; Takagaki Y; Yamada K; Inoue K; Shinka S
    J Immunol; 1985 Jul; 135(1):47-52. PubMed ID: 2582043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of action of immunological adjuvants.
    Allison AC
    J Reticuloendothel Soc; 1979 Dec; 26(Suppl):619-30. PubMed ID: 392086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.